Context Capital Management, LLC - LIGAND PHARMACEUTICALS INC ownership

LIGAND PHARMACEUTICALS INC's ticker is and the CUSIP is 53220KAF5. A total of 51 filers reported holding LIGAND PHARMACEUTICALS INC in Q4 2019. The put-call ratio across all filers is - and the average weighting 0.3%.

Quarter-by-quarter ownership
Context Capital Management, LLC ownership history of LIGAND PHARMACEUTICALS INC
ValueSharesWeighting
Q2 2021$5,414,000
-58.2%
5,437
-56.3%
0.50%
-60.5%
Q1 2021$12,966,000
+265.2%
12,437
+232.3%
1.27%
+161.5%
Q4 2020$3,550,000
+5.2%
3,743
-99.9%
0.49%
-33.8%
Q3 2020$3,376,000
-39.4%
3,743,000
-41.1%
0.73%
-66.1%
Q2 2020$5,569,000
+183.0%
6,350,000
+170.2%
2.17%
+93.9%
Q1 2020$1,968,000
-3.0%
2,350,0000.0%1.12%
+9.9%
Q4 2019$2,028,000
-54.5%
2,350,000
-56.1%
1.02%
-59.8%
Q3 2019$4,459,000
+281.4%
5,350,000
+296.3%
2.53%
+272.7%
Q2 2019$1,169,0001,350,0000.68%
Other shareholders
LIGAND PHARMACEUTICALS INC shareholders Q4 2019
NameSharesValueWeighting ↓
Penn Mutual Asset Management 1,214,000$1,164,0001.57%
TFG Asset Management GP Ltd 21,600,000$21,027,0001.44%
TENOR CAPITAL MANAGEMENT Co., L.P. 11,645,000$11,336,0000.26%
OAKTREE CAPITAL MANAGEMENT LP 20,472,000$19,704,0000.23%
PALISADE CAPITAL MANAGEMENT, LP 5,952,000$5,782,0000.16%
SSI INVESTMENT MANAGEMENT LLC 2,000,000$1,916,0000.12%
Cutler Capital Management, LLC 300,000$287,0000.11%
Radcliffe Capital Management, L.P. 3,117,000$2,985,0000.07%
PROSPECTOR PARTNERS LLC 400,000$383,0000.06%
Financial Sense Advisors, Inc. 130,000$125,0000.05%
View complete list of LIGAND PHARMACEUTICALS INC shareholders